Finally, for the third comparison method, LoS registered an increased deposition of 1.05 percentage points relative to CU (1.90% vis--vis 0.86%)
Flags theoretical pathologic angiogenesis potential: PMC12446177 Evidence Summary Preclinical: IBD/colitis models: High remission rates, restored mucosal architecture, improved barrier function Tendon repair: Accelerated healing, improved tensile strength, reduced fibrosis Neurovascular: Sciatic nerve protection, enhanced blood vessel growth in nerve tissue Human data (emerging): Interstitial cystitis pilot (2024, n=12): 10/12 complete resolution, 2/12 at 80% improvement IV safety study (2025, n=2): no adverse effects on cardiac, hepatic, renal, or glucose biomarkers Knee pain retrospective (2021, n=17): 91.6% reported significant improvement No large-scale controlled trials published Safety: No immunosuppression or hormonal disruption in available data 2025 systematic review (HSS Journal): recommends caution due to limited high-quality clinical evidence 2025 narrative review: flags theoretical pathologic angiogenesis risk Stable in gastric acid (oral administration viable) No observed toxicity at therapeutic doses in published reports Foundational Reviews Sikiric P, Seiwerth S, et al
To insure solubility and peptide stability Acetic Acid 0.6% solution should be used to reconstituite
Aflatoxins in breast milk, neonatal cord blood and sera of pregnant women
Proper diagnosis and treatment of Vitamin B12 deficiency are critical, yet sometimes complications can arise during therapy
Some clinics also refer to formulations that include additional compounds as liver detox injections, given the role these nutrients play in supporting hepatic fat metabolism and detoxification
